Institutional investors hold a majority ownership of MYL through the 91.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2014, these large investors purchased a net $2.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OZ MANAGEMENT LP Bought 5.9 Million shares of Mylan Inc
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 5.6 Million shares of Mylan Inc
MUNDER CAPITAL MANAGEMENT Bought 1.9 Million shares of Mylan Inc